ST-2427

N/A

Report date: 2024/05/15 16:09:08
NME

Base Information

Drug NameST-2427
Drug Alias NameST-2427
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type IX alpha subunit inhibitors
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsAcute PainPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSiteone Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAcute PainPain, Postoperative

Other Information

ATC CodeN/A
Related LinksN/A